Get started
Author

Sandra Santarossa

Observed names: S Santarossa, S. Santarossa
ORCID: 0000-0002-7134-640X
Observed ORCID: 0000-0002-7134-640X
OpenAlex ID: A5007626838
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
2024 · Robert J. Motzer, Camillo Porta, et al. · Journal of Clinical Oncology · 196
Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study
2014 · Orazio Caffo, Ugo De Giorgi, et al. · European Urology · 83
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
2012 · Alessandra Bearz, Renato Talamini, et al. · BMC Research Notes · 58
PDF
A Risk and Benefit Assessment of Treatment for AIDS-Related Kaposi??s Sarcoma
1999 · Guglielmo Nasti, Domenico Errante, et al. · Drug Safety · 27
Concomitant Chop Chemotherapy (ct) and Highly Active Antiretroviral Therapy (haart) in Patients (pts) With Hiv-related Non-hodgkin's Lymphoma (hiv-nhl).
1998 · E. Vaccher, M. Spina, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 12
Solitary meningeal recurrence in a patient with transitional cell carcinoma of the bladder with locally bulky disease at presentation
1997 · Sandra Santarossa, Emanuela Vaccher, et al. · Journal of Neuro-Oncology · 12
Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
2014 · Alessandra Bearz, Sandra Santarossa, et al. · BMC Research Notes · 10
PDF
Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report
2018 · Elisa De Carlo, Monica Schiappacassi, et al. · OncoTargets and Therapy · 5
PDF
[Emerging ethical issues in clinical practice: a regional survey].
2021 · Giuliana Pitacco, Nadia Urli, et al. · PubMed · 4
Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience
2018 · Elisa De Carlo, Maria Chiara Del Savio, et al. · Oncotarget · 4
PDF
Ribonucleotide reductase inhibition in the treatment of advanced prostate cancer: an experimental approach with hydroxyurea and gallium nitrate in 20 patients
1995 · S. Santarossa, E. Vaccher, et al. · European Journal of Cancer · 4
Second-line Chemotherapy (ct) With Cde (cyclophosphamide, Doxorubicin, Etoposide) in Patients (pts) With Resistant Human Immunodeficiency Virus-related Non-hodgkin's Lymphoma (hiv-nhl)
1998 · D. Errante, S. Santarossa, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 3
Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patients
1994 · A Veronesi, G Lo Re, et al. · European Journal of Cancer · 3
Epirubicin, Bleomycin, Vinblastine and Prednisone (ebvp) Chemotherapy(ct) in Combination With Antiretoviral Therapy and Primary Use of G-csf for Patients (pts) With Hodgkin's Disease and Hiv Infection (hd-hiv).
1997 · U. Tirelli, D. Errante, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 2
LC-MS/MS Method for Therapeutic Drug Monitoring of Abiraterone, Darolutamide, Apalutamide, Enzalutamide, and Metabolites in Prostate Cancer Patients
2026 · Bianca Posocco, Diletta Pasin, et al. · International Journal of Molecular Sciences · 1
PDF
Prospective phase II study of sunitinib rechallenge in metastatic renal cell carcinoma: The “retry” study from the Italian Group of Onco-Nephrology (G.I.O.N.)
2022 · Camillo Porta, Vittorio Ferrari, et al. · Journal of Onco-Nephrology · 1
Weekly cabazitaxel in elderly patients (EP) with metastatic castration resistant prostate cancer (mCRPC) progressing after docetaxel treatment: WeCabE, a phase II study.
2018 · Bruno Castagneto, Ilaria Stevani, et al. · Journal of Clinical Oncology · 1
Prospective phase II study of sunitinib rechallenge in metastatic renal cell carcinoma (mRCC): A G.I.O.N. trial.
2017 · Camillo Porta, Vittorio D. Ferrari, et al. · Journal of Clinical Oncology · 1
181 O - HIV-related cervical cancer (CA) in Italy; a report of 54 cases from the Italian cooperative group on aids and tumors (GICAT)
1996 · S. Santarossa, E. Vaccher, et al. · European Journal of Cancer · 1
183 P - Age and LDH are independent prognostic factors also in HIV-related non-hodgkin's lymphoma (HIV-NHL): a monoinstitutional study of 96 patients (pts)
1996 · E. Vaccher, M. Spina, et al. · European Journal of Cancer · 1
2402P Real-world experience with radium-223 dichloride in mCRPC: A single-center retrospective analysis
2025 · G. Bortolus, R. Bortolus, et al. · Annals of Oncology
IUC24414-80 Optimizing sunitinib therapy in mRCC through pharmacological counseling and early TDM integration
2025 · G Bortolus, E Cecchin, et al. · The Oncologist
78P The integration of TDM and PGx in patients with mRCC receiving sunitinib treatment
2025 · G. Bortolus, E. Cecchin, et al. · ESMO Open
P198 Applying TDM and PGx in mRCC patients treated with Sunitinib to customize drug dosing
2024 · G. Bortolus, E. Cecchin, et al. · European Urology Open Science
95P Implementation of TDM and PGx in mRCC patients treated with sunitinib to personalize drug dosing
2024 · G. Bortolus, E. Cecchin, et al. · ESMO Open
PDF
Works count: 29
Citation count: 429
H-index: 7
I10-index: 7
Year
Topic
Type